These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 24861991)
21. Effect of statin therapy on incident type 2 diabetes mellitus in patients with clinically manifest vascular disease. van de Woestijne AP; van der Graaf Y; Westerink J; Nathoe HM; Visseren FL Am J Cardiol; 2015 Feb; 115(4):441-6. PubMed ID: 25554536 [TBL] [Abstract][Full Text] [Related]
22. Effects of background statin therapy on glycemic response and cardiovascular events following initiation of insulin therapy in type 2 diabetes: a large UK cohort study. Anyanwagu U; Mamza J; Donnelly R; Idris I Cardiovasc Diabetol; 2017 Aug; 16(1):107. PubMed ID: 28830436 [TBL] [Abstract][Full Text] [Related]
23. An examination of the effect of cytochrome P450 drug interactions of hydroxymethylglutaryl-coenzyme A reductase inhibitors on health care utilization: a Canadian population-based study. Einarson TR; Metge CJ; Iskedjian M; Mukherjee J Clin Ther; 2002 Dec; 24(12):2126-36. PubMed ID: 12581550 [TBL] [Abstract][Full Text] [Related]
24. Effect of pravastatin in people with diabetes and chronic kidney disease. Tonelli M; Keech A; Shepherd J; Sacks F; Tonkin A; Packard C; Pfeffer M; Simes J; Isles C; Furberg C; West M; Craven T; Curhan G J Am Soc Nephrol; 2005 Dec; 16(12):3748-54. PubMed ID: 16251235 [TBL] [Abstract][Full Text] [Related]
25. Differences between statins on clinical endpoints: a population-based cohort study. Dieleman JP; van Wyk JT; van Wijk MA; van Herpen G; Straus SM; Dunselman H; Sturkenboom MC Curr Med Res Opin; 2005 Sep; 21(9):1461-8. PubMed ID: 16197665 [TBL] [Abstract][Full Text] [Related]
26. Use of metformin and risk of kidney cancer in patients with type 2 diabetes. Tseng CH Eur J Cancer; 2016 Jan; 52():19-25. PubMed ID: 26630530 [TBL] [Abstract][Full Text] [Related]
27. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study. Ou HT; Chang KC; Li CY; Wu JS Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742 [TBL] [Abstract][Full Text] [Related]
28. Fracture risk and healthcare resource utilization and costs among osteoporosis patients with type 2 diabetes mellitus and without diabetes mellitus in Japan: retrospective analysis of a hospital claims database. Sato M; Ye W; Sugihara T; Isaka Y BMC Musculoskelet Disord; 2016 Nov; 17(1):489. PubMed ID: 27887655 [TBL] [Abstract][Full Text] [Related]
29. Risk of type 2 diabetes mellitus in female breast cancer patients treated with morphine: A retrospective population-based time-dependent cohort study. Yang SP; Muo CH; Wang IK; Chang YJ; Lai SW; Lee CW; Morisky DE Diabetes Res Clin Pract; 2015 Dec; 110(3):285-90. PubMed ID: 26515910 [TBL] [Abstract][Full Text] [Related]
30. Risk for incident diabetes mellitus following initiation of second-generation antipsychotics among Medicaid-enrolled youths. Rubin DM; Kreider AR; Matone M; Huang YS; Feudtner C; Ross ME; Localio AR JAMA Pediatr; 2015 Apr; 169(4):e150285. PubMed ID: 25844991 [TBL] [Abstract][Full Text] [Related]
31. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus. Tseng CH Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464 [TBL] [Abstract][Full Text] [Related]
32. Diabetes increases the risk of deep-vein thrombosis and pulmonary embolism. A population-based cohort study. Chung WS; Lin CL; Kao CH Thromb Haemost; 2015 Oct; 114(4):812-8. PubMed ID: 26271946 [TBL] [Abstract][Full Text] [Related]
33. Statin-associated incident diabetes: a literature review. Park ZH; Juska A; Dyakov D; Patel RV Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689 [TBL] [Abstract][Full Text] [Related]
34. A comparison of low versus standard dose pravastatin therapy for the prevention of cardiovascular events in the elderly: the pravastatin anti-atherosclerosis trial in the elderly (PATE). Ito H; Ouchi Y; Ohashi Y; Saito Y; Ishikawa T; Nakamura H; Orimo H J Atheroscler Thromb; 2001; 8(2):33-44. PubMed ID: 11770708 [TBL] [Abstract][Full Text] [Related]
35. Statin Use and Gastrointestinal Hemorrhage: A Large Retrospective Cohort Study. Martinez AI; Freeman PR; Moga DC Am J Cardiovasc Drugs; 2019 Feb; 19(1):65-74. PubMed ID: 30255477 [TBL] [Abstract][Full Text] [Related]
36. Factors associated with statin selection among privately insured commercial and Medicare patients. Zhao Z; Bae J; Sponseller CA; Zhu Y; Kryzhanovski VA; LeNarz LA Curr Med Res Opin; 2013 Apr; 29(4):395-404. PubMed ID: 23406054 [TBL] [Abstract][Full Text] [Related]
37. Risk of type 2 diabetes mellitus in patients with acute critical illness: a population-based cohort study. Hsu CW; Lin CS; Chen SJ; Lin SH; Lin CL; Kao CH Intensive Care Med; 2016 Jan; 42(1):38-45. PubMed ID: 26370689 [TBL] [Abstract][Full Text] [Related]
38. Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis. McAdams M; Staffa J; Dal Pan G Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):229-39. PubMed ID: 18175291 [TBL] [Abstract][Full Text] [Related]